Quick Answer
GRI Bio, Inc. reported Operating Income of -$11.98 million for fiscal year 2025.
GRI Bio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$11.98M | -45.4% |
| 2024 | -$8.23M | +27.7% |
| 2023 | -$11.39M | -408.6% |
| 2022 | -$2.24M | +75.8% |
| 2021 | -$9.26M | -93.4% |
| 2020 | -$4.79M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.37M | -58.0% | -16.2% |
| June 30, 2025 | -$2.90M | -28.4% | +5.0% |
| March 31, 2025 | -$3.05M | -61.0% | -43.2% |
| September 30, 2024 | -$2.13M | +12.7% | +5.6% |
| June 30, 2024 | -$2.26M | +62.0% | -19.1% |
| March 31, 2024 | -$1.90M | -91.8% | +22.3% |
| September 30, 2023 | -$2.44M | -1211.3% | +58.9% |
| June 30, 2023 | -$5.93M | -3039.7% | -500.6% |
- GRI Bio, Inc. showed a decrease of -45.4% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, GRI Bio, Inc.’s operating income has declined by 150.1% (from -$4.79 million to -$11.98 million).
- The most recent figure is from GRI Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: